BS EN ISO 10993-18:2020
$215.11
Biological evaluation of medical devices – Chemical characterization of medical device materials within a risk management process
Published By | Publication Date | Number of Pages |
BSI | 2020 | 84 |
This document specifies a framework for the identification, and if necessary, quantification of constituents of a medical device, allowing the identification of biological hazards and the estimation and control of biological risks from material constituents, using a generally stepwise approach to the chemical characterization which can include one or more of the following:
-
the identification of its materials of construction (medical device configuration);
-
the characterization of the materials of construction via the identification and quantification of their chemical constituents (material composition);
-
the characterization of the medical device for chemical substances that were introduced during manufacturing (e.g. mould release agents, process contaminants, sterilization residues);
-
the estimation (using laboratory extraction conditions) of the potential of the medical device, or its materials of construction, to release chemical substances under clinical use conditions (extractables);
-
the measurement of chemical substances released from a medical device under its clinical conditions of use (leachables).
This document can also be used for chemical characterization (e.g. the identification and/or quantification) of degradation products. Information on other aspects of degradation assessment are covered in ISO 10993-9, ISO 10993-13, ISO 10993-14 and ISO 10993-15.
The ISO 10993 series is applicable when the material or medical device has direct or indirect body contact (see ISO 10993-1 for categorization by nature of body contact).
This document is intended for suppliers of materials and manufacturers of medical devices, to support a biological evaluation.
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | undefined |
6 | Annex ZA (informative)Relationship between this European standard and the General Safety and Performance Requirements of Regulation (EU) 2017/745 aimed to be covered |
8 | Annex ZB (informative)Relationship between this European Standard and the essential requirements of Directive 90/385/EEC [OJ L 189] aimed to be covered |
10 | Annex ZC (informative)Relationship between this European standard and the General Safety and Performance Requirements of Regulation (EU) 2017/745 aimed to be covered |
13 | Foreword |
14 | Introduction |
16 | 1 Scope 2 Normative references |
17 | 3 Terms and definitions |
21 | 4 Symbols and abbreviated terms |
22 | 5 Characterization procedure 5.1 General |
25 | 5.2 Establish medical device configuration and material composition 5.2.1 General |
26 | 5.2.2 Information gathering 5.2.3 Information generation |
27 | 5.3 Assess material/chemical equivalence to a clinically established material or medical device |
28 | 5.4 Assess the hypothetical worst-case chemical release based on total exposure to the medical device’s chemical constituents 5.4.1 Establish the hypothetical worst-case chemical release 5.4.2 Assess the hypothetical worst-case chemical release |
29 | 5.5 Establish an analytical evaluation threshold 5.6 Estimate the chemical release; perform extraction study |
32 | 5.7 Assess the estimated chemical release (extractables profile) 5.8 Determine the actual chemical release; perform leachables study |
34 | 5.9 Assess the actual chemical release (leachables profile) 5.10 Exiting the chemical characterization process 6 Chemical characterization parameters and methods 6.1 General |
35 | 6.2 Material composition |
37 | 6.3 Extractables and leachables |
39 | 6.4 Structural composition or configuration |
40 | 6.5 Analytical methods |
41 | 7 Reporting of the chemical characterization data |
42 | Annex A (informative) General principles of chemical characterization |
46 | Annex B (informative) Information sources for chemical characterization |
50 | Annex C (informative) Principles for establishing biological equivalence |
53 | Annex D (informative) Principles of sample extraction |
65 | Annex E (informative) Calculation and application of the analytical evaluation threshold (AET) |
73 | Annex F (informative) Qualification of analytical methods used for extractables/leachables |
76 | Annex G (informative) Reporting details for analytical methods and chemical data |
79 | Bibliography |